top of page
Catherine Unsworth
Catherine joined the Rannard group in October 2017 to develop nanoformulations of novel antiretrovirals for oral and injectable delivery for the treatment of HIV. Catherine has worked on a diverse range of analytical projects from chondritic meteorites to alkali-activated waste materials as cement replacements. She obtained an MSc in Environmental Analysis and Assessment and an MSci in Geology before studying for a PhD on nanomedicine techniques to enable the development of parenterally-administered therapeutic candidates. Catherine started working for the Centre of Excellence for long-acting Therapeutics (CELT) as part of the Unitaid-funded LONGEVITY project working on an injectable cure for hepatitis C
bottom of page